Linezolid Sandoz (Linezolid)

Linezolid is indicated for infections caused by Gram‑positive bacteria, targeting resistant strains and respiratory or skin conditions.

• Methicillin‑resistant Staphylococcus aureus (MRSA): effective treatment of infections caused by MRSA.
• Community‑acquired pneumonia: improves outcomes in adult patients with pneumonia due to susceptible organisms.
• Skin and soft‑tissue infections: resolves infections such as cellulitis and abscesses caused by Gram‑positive pathogens.

• Linezolid inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome, preventing formation of the initiation complex. This action blocks the translation of essential proteins, resulting in a bacteriostatic effect against most susceptible Gram‑positive organisms, including resistant strains such as MRSA and VRE. The binding site is distinct from those of other antibiotic classes, which reduces cross‑resistance. Linezolid’s activity is concentration‑independent and it penetrates well into lung tissue and skin.

Linezolid may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Diarrhea: loose stools that may be watery.
• Headache: transient cranial discomfort.
• Metallic taste: altered taste sensation in the mouth.

Serious or Rare Side Effects

• Thrombocytopenia: significant drop in platelet count, increasing bleeding risk.
• Peripheral neuropathy: tingling or numbness in extremities, potentially irreversible.
• Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents.

When prescribing Linezolid, clinicians should consider several safety aspects to minimize risk.

• Renal impairment: adjust monitoring as renal function may affect drug clearance.
• Hepatic impairment: use with caution and monitor liver enzymes.
• Hematologic monitoring: perform regular complete blood counts to detect thrombocytopenia or anemia.
• Serotonergic agents: avoid concomitant use due to risk of serotonin syndrome.
• Pregnancy and lactation: safety not established; weigh benefits against potential risks.
• Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Linezolid interacts with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic drugs: may precipitate serotonin syndrome.
• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis and serotonin syndrome.
• Rifampin: induces hepatic enzymes, markedly decreasing linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

• Warfarin: linezolid may enhance anticoagulant effect, monitor INR.
• Oral contraceptives: efficacy may be reduced, advise alternative contraception.
• Phenytoin and carbamazepine: may lower linezolid levels, monitor clinical response.